Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 4, 1999, Pages 353-361

  Cantinieaux, B ^a,b,c,d   Janssens, A ^a,b,c,d   Boelaert, J R ^a,b,c,d   Lejeune, M ^a,b,c,d   Vermylen, C ^a,b,c,d   Kerrels, V ^a,b,c,d   Cornu, G ^a,b,c,d   Winand, J ^a,b,c,d   Fondu, P ^a,b,c,d  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^b General Hospital St Jan   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033117528     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90066-5     Document Type: Article

References (43)

1. 1. Weinberg ED. Iron and infection. Microbiol Rev 1978:42:45-66.
2. 2. Bullen JJ. The significance of iron in infection. Rev Infect Dis 1981;3:1127-38.
3. 3. Finkelstein RA, Sciortino CV, McIntosh MA. Role of iron in microbe-host interactions. Rev Infect Dis 1983:554:5759-77.
4. 4. Kluger MJ, Bullen JJ. Clinical and physiological aspects. In: Bullen JJ, Griffiths E, editors. Iron and infection. New York: John Wiley & Sons Ltd; 1987.
5. 5. Boelaert JR, Van Landuyt HW, Valcke YJ, Cantinieaux B, Lornoy WF, Vanherweghem JL, et al. The role of iron overload in Yesinia enterocolitica and Yersinia pseudotuberculosis bacteraemia in hemodialysis patients. J Infect Dis 1987; 156:384-7.
6. 6. Van Asbeck BS, Marx JJM, Struyvenberg A, Verhoef J. Functional defects in phagocytic cells from patients with iron overload. J Infect 1984:8:232-40.
7. 7. Cantinieaux B, Hariga C, Clumeck N, De Maertelaere E, Glupzyneski Y, Magrez P, et al. The role of excess iron in the pathogenesis of disturbed neutrophil functions in cirrhotic patients. Acta Clin Belg 1987;42:153-62.
8. 8. Cantinieaux B, Hariga C, Ferster A, De Maertelaere E, Toppet M, Fondu R Neutrophil dysfunctions in thalassaemia major: the role of cell iron overload. Hur J Haematol 1987:39:28-34.
9. 9. Skoutelis ATH, Lianou E, Papavassiliou TH, Karamerou A, Politi K, Bassaris HP. Defective phagocytic and bactericidal function of polymorphonuclear leukocytes in patients with β-thalassaemia major. J Infect 1984;8:118-22.
10. 10. Waterlot Y, Cantinieaux B, Hariga-Müller C, De Maertelaere-Laurent E, Vanherweghem JL, Fondu P. Impairment of neutrophil phagocytosis in haemodialysed patients: the critical role of iron overload. Br Med J 1985;291:501-4.
11. 11. Cantinieaux B, Boelaert J, Hariga C, Fondu P. Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis. J Lab Clin Med 1988;111:524-8.
12. 12. Cantinieaux B, Hariga C, Ferster A, Toppet M, Fondu P. Desferrioxamine improves neutrophil phagocytosis in thalassaemia major. Am J Hematol 1990;35:13-7.
13. 13. Boelaert JR, Cantinieaux BF, Hariga CF, Fondu PG. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 1990;5:504-7.
14. 14. Hoepelman IM, Bezemer WA, Van Doormalen H, Verhoet J, Marx JJM. Lipid peroxidation of human granulocytes (PMN) and monocytcs (MN) by iron complexes. Br J Haematol 1989,72:584.
15. 15. Britigan BE, Rosen GM, Chai Y, Cohen MS. Do human neutrophils make hydroxyl radical? J Biol Chem 1986;261:4426-31.
16. 16. Cantinieaux B, Boelaert JR, De Meuleneire Y, Kerrels V, Fondu P, Neutrophils from patients with secondary hemosiderosis contain excessive amounts of autotoxic iron. Eur J Haematol 1993;51:161-5.
17. 17. Pootrakul J, Josephson B, Huebers HA, Finch CA, Quantitation of ferritin iron in plasma, an explanation for non-transferrin iron. Blood 1988;71:1120-3.
18. 18. Winterboum CC, Monteiro HP, Galilee CF. Ferritin-dependent lipid peroxidation by stimulated neutrophils: inhibition by myeloperoxidase-derived hypochlorous acid but not by endogenous lactoferrin. Biochim Biophys Acta 1990;1055:179-85.
19. 19. Abdalla DS, Campa A, Monteiro HP. Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Arteriosclerosis 1992;110:87-91.
20. 20. Moss D, Powell LW, Arosio P, Halliday JW. Characterization of the ferritin receptors on human T lymphoid (molt4) cells. J Lab Clin Med 1992;119:273-9.
21. 21. Covell AM, Cook JD. Interaction of acidic isoferritins with human promyelocytic HL60 cells. Br J Haematol 1988:69:559-63.
22. 22. Hann HW, Sthalhut MW, Lee S, London T, Hann RS. Effects of isoferritins on human granulocytes. Cancer 1989;63:2492-6.
23. 23. Edwards SW. Neutrophil priming: regulation of neutrophil function during inflammatory activation. In: Biochemistry and physiology of the neutrophil. Cambridge: Cambridge University Press; 1994. p. 235-63.
24. 24. Cantinieaux B, Hariga C, Courtoy P, Hupin J, Fondu P. Staphylococcus aureus phagocytosis, A new cytofluorometric method using FITC and paraformaldehyde. J Immunol Methods 1989;121:203-8.
25. 25. Cantinieaux B, Courtoy P, Fondu P. Accurate flow cytometric measurements of bacteria concentrations. Pathobiology 1993;61:95-7.
26. 26. Hed J, Hallden G, Johansson SGO, Larsson P. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods 1987; 101:119-22.
27. 27. Michel O, Duchateau J, Plat G, Cantinieaux B, Hotimsky A, Gerain J, et al. Blood inflammatory response to inhaled endotoxin in normal subjects. Clin Exp Allergy 1995;25:73-9.
28. 28. Lejeune M, Sariban E, Cantinieaux B, Ferster A, Devalck C, Fondu P. Transient alterations of polymorphonuclear neutrophil functions in children exposed to chemotherapy. Pediatr Res 1996;39:835-42.
29. 29. Ferrali M, Signorini C, Ciccoli L, Comporti M. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil. Biochem J 1992;85:295-8.
30. 30. Hupin J, Cantinienux B, Fondu P. Applications of the monoclonal antibody PC10 assessment of proliferative grade in cell smears. Am J Clin Pathol 1993:99:673-6.
31. 31. Brock JH. Iron and the immune system. In: Lauffer RB, editor. Iron and human disease. Boca Raton, FL: CRC Press; 1992. p. 161-78.
32. 32. Britigan BE, Roeder TL, Shasby DM. Insight into the nature and site of oxygen-centered free radical generation by endothelial cell monolayers using a novel spin trapping technique. Blood 1992;79:699-707.
33. 33. Porter JB, Abeysinghe RD, Marshall L, Hider RC, Singh S. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 1996;88:705-13.
34. 34. Brieland JK, Fantone JC. Ferrous iron release from transferrin by human neutrophil-derived Superoxide anion: effect of pH and iron saturation. Arch Biochem Biophys 1991:284:78-83.
35. 35. Parmley RT, Hajdu I, Denijs FR. Ultrastructural localization of the transferrin receptor and transferrin on marrow cell surfaces. Br J Haematol 1983:54:633-41.
36. 36. Gutteridge JMC. Lipid peroxidation initiated by superoxide-dependent hydroxyl radicals using complexed iron and hydrogen peroxide. FEBS Lett 1984; 172:245-9.
37. 37. Morikawa K, Oseko F, Morikawa S. H-and L-rich ferritins suppress antibody production, but not proliferation, of human B lymphocytes in vitro. Blood 1994;83:737-41.
38. 38. Broxmeyer HE, Bognacki J, Dorner MH, Sousa M. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages. J Exp Med 1981:153:1426-8.
39. 39. Matzner Y, Hcrshko C, Polliaek A, Konijn AM, Izak G. Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol 1979:42:345-8.
40. 40. Matzner Y, Konijn AM, Shlomai Z, Ben-Bassat H. Differential effect of isolated placental isoferritins on in vitro T-lymphocyte function. Br J Haematol 1985:59:443-8.
41. 41. Keiwn P, Descamps-Latscha B. In vitro suppression of cell-mediated immunity by ferroproteins and ferric salts. Cell Immunol 1983:9080:257-9.
42. 42. Brock JH. Iron and Immunity. J Nutr Immunol 1993;2:47-9.
43. 43. Harada T, Baba M, Torii I, Morikawa S. Ferritin selectively suppresses delayed-type hypersensitivity responses at induction or effector phase. Cell Immunol 1987:109:75-8.